SERUM MYELOPEROXIDASE, MALONDIALDEHYDE, ALPHA-SYNUCLEIN LEVELS IN PATIENTS WITH EPILEPSY
Background: Processes such as neurodegeneration, hypoxia, blood brain barrier dysfunction and oxidative changes are effective for epileptogenesis.There is no non-invasive biomarker that can be used in the follow-up of patients with epilepsy, which is a neurodegenerative disease. Objective: In ou...
Guardado en:
Autores principales: | Fatma Şimşek, Mustafa Ceylan, Seda Aşkın, Ahmet Kızıltunç |
---|---|
Formato: | article |
Lenguaje: | EN ID |
Publicado: |
University of Brawijaya
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b7263580af3a421b9d8d6206fc5601e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Rachel Kelly, et al.
Publicado: (2021) -
Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Tian-Sin Fan, et al.
Publicado: (2021) -
Dynamics of the Level of Myeloperoxidase and Serum Calprotectin in Local Cold Injury
por: M. I. Mikhailichenko, et al.
Publicado: (2020) -
Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation
por: Stefania Vogiatzis, et al.
Publicado: (2021) -
Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration
por: Mantas Ziaunys, et al.
Publicado: (2021)